Improved estrogen reception may sharpen fuzzy memory

July 30, 2008

GAINESVILLE, Fla. - Estrogen treatments may sharpen mental performance in women with certain medical conditions, but University of Florida researchers suggest that recharging a naturally occurring estrogen receptor in the brain may also clear cognitive cobwebs.

The discovery suggests that drugs can be developed to offset "senior moments" related to low estrogen levels, as well as to protect against neurological diseases, all while avoiding the problems associated with adding estrogen to the body.

Writing online in Molecular Therapy in July, scientists with UF's McKnight Brain Institute describe how they improved thought processes in female mice bred with the inability to produce estrogen receptor-alpha, a protein apparently necessary for healthy learning and memory.

"We were able to restore function in these animals, not by dosing them with estrogen, but by enabling them to use the estrogen that was naturally present in their bodies," said Tom Foster, Ph.D., the Evelyn F. McKnight chair for brain research in memory loss at the UF College of Medicine. "We discovered that you can affect the estrogen receptor directly in the hippocampus, right where it's needed to address memory and spatial learning."

Changes in the estrogen receptor have been associated with age-related memory deficits and an increased incidence of Alzheimer's disease among women. In addition, previous studies have shown estrogen replacement may improve cognition in postmenopausal women and younger women with low estrogen levels. Estrogen also appears to protect against Alzheimer's disease and dementia.

The downside is that estrogen is a powerful hormone that has far-reaching effects throughout the body. It has been associated with a slight increase in women's risk for breast cancer, heart disease in patients with existing cardiovascular problems, and stroke.

"Estrogen may act as a growth agent for cancer, but in the brain, it appears to maintain health and counteract stress," Foster said. "We wanted to come back and enhance the signaling pathway that makes estrogen functional. We used a gene therapy technique that enables us to target the brain, but ultimately there could be a pharmaceutical that enhances the signaling pathway solely in the brain."

The mice had unusually low levels of estrogen because their ovaries were removed at an early age. However, scientists were still able to rescue learning ability by delivering the correct gene to produce estrogen receptor-alpha directly to the hippocampus.

Mice that lacked the estrogen receptor showed poor ability to locate a platform hidden in a small swimming tank over a training period of several days. After receiving the gene, the mice learned to locate the platform in two days of training.

"This research shows that when the estrogen receptor-alpha is restored to adult mice that have been missing it their entire lives, it is still possible to enhance memory and learning," said John H. Morrison, Ph.D., dean of basic sciences and the Graduate School of Biological Sciences at Mount Sinai School of Medicine, who did not participate in the research. "This is good news for moving forward to develop clinical interventions and therapeutics because it appears critical damage was not done to brain circuitry during early development. There has also been debate about which of at least two estrogen receptors is key to synaptic health. Clearly estrogen receptor-alpha plays a critically important role in hippocampal organization and function."

Recordings made from the brain tissue of treated mice showed signals were strongly communicated across the gaps, or synapses, between hippocampal cells, similar to what would happen with estrogen replacement.

"Investigating the impact of genetically replacing the estrogen receptor at the cellular, synaptic and behavioral levels is a scientific tour de force which provides a strong foundation for the role of estrogen receptor alpha in mediating estrogen action in the hippocampus to restore select types of memory function," said Roberta Diaz Brinton, Ph.D., a professor of pharmacology and pharmaceutical sciences and biomedical engineering at the University of Southern California, who was not involved in the study. "From a technology perspective, their technique to transfect the estrogen receptor is an exciting advance for researching steroid receptors in the brain."

Studying the effects of increasing the estrogen receptor in other brain regions may shed additional light on memory processes.

"The research brings up the idea that local activation of non-nuclear estrogen receptor-alpha is important for regulating memory processes in the hippocampus," said Teresa A. Milner, Ph.D., a professor of neuroscience at Weill Cornell Medical College, who also was also not involved in the research.

University of Florida

MANAGING EARLY BREAST CANCER: Prognostic features guide choice of therapy Predictors of treatment response, such as lymph node involvement, estrogen receptor ... optimal outcomes. (Postgraduate Medicine)
by JTE Multimedia

In the United States, more than 90% of breast cancer diagnoses occur in an early stage of the disease. That so much detection happens early bodes well for the patient. However, it is only one part of the clinical picture. Various features, such as lymph node involvement and receptor status, help predict outcome, aid in treatment selection, and are crucial factors in survival. Here, the authors present the current considerations and treatment guidelines for early-stage breast cancer. Mirshahidi HR, Abraham J. Managing early breast cancer: prognostic features guide choice of therapy.

Original Publication Date: October 2004

Estrogens, Estrogen Receptor, and Breast Cancer (Biomedical and Health Research, Vol. 36) (Biomedical and Health Research, V. 36)
by Fritz F. Parl (Author)

Estrogens have been implicated to play a role in the development of breast cancer. The purpose of this book is to provide a comprehensive analysis of experimental, clinical and epidemiological evidence in support of the carcinogenicity of estrogens. The book is organized into seven chapters with the first one providing a historical review. The second chapter analyzes estrogen synthesis and metabolism basedo nt he molecular and pharmacogenetic characterization of enzymes that determine estrogen levels in the breast. The next chapter is devoted to the molecular endocrinology of the estrogen receptors alpha and beta, including insights into the crystallographic structure and the interaction with coactivators, cointegrators and chromatin. Chapter four addresses physiological effects of...

Hormone Receptors in Breast Cancer (Cancer Treatment and Research)
by Suzanne A. W. Fuqua (Editor)

Hormone Receptors in Breast Cancer provides an up-to-date resource of the role of hormone receptors in breast cancer written in depth for both the basic molecular academic researcher and translational scientist. Advances in basic science of molecular endocrinology have undoubtedly been translated into clinical practice, and clinicians caring for this disease need to be knowledgeable about these developments. The molecular basis of hormone action has been elucidated, and the relative significance of the different estrogen and progesterone receptor isoforms has been explored. This explosion of information has lead to exciting new areas of gene specific targeting of the disease, and breast cancer prevention. Paradigm shifts in treatment options and sequencing have recently occurred in...

Estrogen alternati tr
by Steven R. Goldstein (Author)

A reader-friendly guide to Hormone Replacement Therapy and the first book to feature SERMs, the new estrogen substitutes....Now women can enjoy the many benefits of estrogen--without all the worry.

"A new alternative to estrogen may offer older women many of the hormone's heart-and-bone-protecting advantages without one of its most worrisome side effects--the increased risk of breast cancer." --Associated Press

Every postmenopausal woman must face the estrogen dilemma. Replacing estrogen lowers the incidence of heart disease, osteoporosis, and Alzheimer's disease--but it also increases the chance of breast and uterine cancer. Until now...New synthetic hormones, SERMs, provide many of the benefits of estrogen without the risks. Written by Steven R. Goldstein, M.D., a...

Estrogen/Antiestrogen Action and Breast Cancer Therapy
by V. Craig Jordan (Author)

This book marks one of the achievements of the “Estrogen and Antiestrogen Action: Basic and Clinical Aspects” Wisconsin Clinical Cancer Center conference in June 1984. It is not intended to be a recount of the meeting proceedings but is, rather, a historical review of the development of this field of endeavor during the past 30 years. The chapters have been written by many of the leading experts in the field who were asked to recount the development of a particular area or laboratory idea in which they had been personally involved. The book is intended to provide both scientists and clinicians with a single-volume overview of both the basic principles of hormonal control of breast cancer and the recent clinical results from cooperative groups around the world.

Selective Estrogen Receptor Modulators (Contemporary Endocrinology)
by Andrea Manni (Editor), Michael Verderame (Editor)

Experimental and clinical researchers from a wide range of disciplines present a wealth of fresh scientific information on the biochemistry, molecular biology, pharmacology, and clinical activity of SERMs. The basic science chapters of the book focus-with an eye to the development of the ideal SERM-on the complex mechanisms of estrogen action, including ligand-dependent conformational changes in alpha and beta, and the recruitment of co-activators and co-repressors which modulate the estrogen receptor transcriptional activity and contribute to its crosstalk with growth factor signaling. The clinical presentation reviews the data accumulated on currently available SERMs, primarily tamoxifen and raloxifene, in cancer treatment and prevention, as well as their effects on the reproductive,...

Estrogen receptors in human breast cancer
by Raven Press (Publisher)

The Estrogen Receptor As Target for Rational Drug Design (Molecular Biology Intelligence Unit)
by Erwin, Ph.D. Von Angerer (Author)

New Molecular Mechanisms of Estrogen Action and Their Impact on Future Perspectives in Estrogen Therapy
by K.H. Fritzemeier (Author), Kenneth S. Korach (Editor), Alexander Hillisch (Editor), Karl Heinrich Fritzemeier (Editor)

This volume is based on the international workshop on "New Molecular Mechanisms of Estrogen Action and Their Impact on Future Perspectives of Estrogen Therapy" held in Berlin, 5-7 March, 2003. Researchers from industry and leading academic laboratories describe recent findings on the mechanisms of estrogen action via different ER subtypes, the interaction of ERs with different cofactors, and the action of ERs through different pathways including non-genomic mechanisms. Furthermore, the book provides information on (a) the biological functions of the two ER subtypes, ERa and ERb, as concluded from different gene-knockout models, (b) the design and synthesis of new selective estrogens, and (c) possible clinical applications for new selective estrogens. All chapters are written by leading...

Steroid Hormone Receptors: Structure and Function (Nobel Symposium Proceedings)
by Hakan Eriksson (Editor), Jan-Ake Gustafsson (Editor)